Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-01-02 @ 5:58 PM
Study NCT ID:
NCT05384756
Status:
RECRUITING
Last Update Posted:
2024-12-31
First Post:
2022-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
Sponsor:
Organization: